|
|
Volumn 11, Issue SUPPL. 1, 2001, Pages 49-54
|
|
Antithrombotic therapy in the acute phase: New approaches
|
|
Author keywords
Abciximab; Ancrod; Antiplatelet agents; Aspirin; GPIIb IIIa inhibitors; Heparin; Heparinoids; Ischemic stroke
|
|
Indexed keywords
ABCIXIMAB;
ACETYLSALICYLIC ACID;
ANCROD;
DANAPAROID;
HEPARINOID;
LOW MOLECULAR WEIGHT HEPARIN;
ANTICOAGULATION;
BLOOD CLOT LYSIS;
BRAIN HEMORRHAGE;
CEREBROVASCULAR ACCIDENT;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE COURSE;
DOSE CALCULATION;
DRUG EFFICACY;
DRUG SAFETY;
FIBRINOGEN BLOOD LEVEL;
HEART INFARCTION;
HUMAN;
MAJOR CLINICAL STUDY;
MORTALITY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RECEPTOR BLOCKING;
TREATMENT OUTCOME;
ACUTE DISEASE;
CEREBROVASCULAR ACCIDENT;
FIBRINOLYTIC AGENTS;
HUMANS;
THROMBOLYTIC THERAPY;
|
|
EID: 0035108872
PISSN: 10159770
EISSN: None
Source Type: Journal
DOI: 10.1159/000049125 Document Type: Conference Paper |
|
Times cited : (3)
|
|
References (9)
|
